<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: No Time for Quality</title>
	<atom:link href="http://blog.pharmtech.com/2008/03/27/no-time-for-quality/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2008/03/27/no-time-for-quality/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: smileeo</title>
		<link>http://blog.pharmtech.com/2008/03/27/no-time-for-quality/comment-page-1/#comment-496</link>
		<dc:creator>smileeo</dc:creator>
		<pubDate>Thu, 24 Apr 2008 09:41:59 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=56#comment-496</guid>
		<description>good news.</description>
		<content:encoded><![CDATA[<p>good news.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Erik Skibsted</title>
		<link>http://blog.pharmtech.com/2008/03/27/no-time-for-quality/comment-page-1/#comment-70</link>
		<dc:creator>Erik Skibsted</dc:creator>
		<pubDate>Thu, 03 Apr 2008 14:29:39 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=56#comment-70</guid>
		<description>I totally agree

I think that the major obstacle is qualified persons within pharma companies. You need people with training in design of experiments, chemometrics, preferably spectroscopy techniques and finally business understanding in order to invest your efforts to maximize outcome.

At least you need a leader that understands (do not have to master) these disciplines and can assemble and guide a team with specialists in order to stear a QbD development process.

Erik</description>
		<content:encoded><![CDATA[<p>I totally agree</p>
<p>I think that the major obstacle is qualified persons within pharma companies. You need people with training in design of experiments, chemometrics, preferably spectroscopy techniques and finally business understanding in order to invest your efforts to maximize outcome.</p>
<p>At least you need a leader that understands (do not have to master) these disciplines and can assemble and guide a team with specialists in order to stear a QbD development process.</p>
<p>Erik</p>
]]></content:encoded>
	</item>
</channel>
</rss>
